Preparation of magnetically recoverable mesoporous silica nanocomposites for effective adsorption of urea in simulated serum

Sustainable urea treatment by environmental-friendly and highly hydrophilic vesicle-like iron phosphate-based carbon

Despite the versatile potential applications of urea, its unfavorable characteristics for conventional treatment methods hinder its utilization. Therefore, this study developed vesicle-like iron phosphate-based carbon (IP@C400) as a breakthrough urea removal and recovery material for a wide range of urea-containing sources. IP@C400 rapidly exhibited an exceptional capacity (2242 mg/g in 1 h) across a wide range of pH, even in synthetic hemodialysis wastewater with high urea concentrations and diverse co-existing components, compared with the 60 prominent adsorbents. The adsorption process followed dual Pseudo-kinetic, Langmuir-isotherm models with the involvement of primary robust physical (i.e., H-bonding and electrostatic interaction) and chemical mechanisms (i.e., hydrolysis). Remarkably, IP@C400 can maintain high urea removal (90 %) or recovery efficiency (95 %) even after 10 cycles with minimal leakages of Fe and P (far below WHO and EUWFD standards)-a significant improvement over disposable options. IP@C400 could also perform efficiently on batch and a new approach integrating with a naturally accessible material based on the fixed-bed column using low-range urea realistic samples, achieving 65.2 L water over 10 cycles with undetected urea, neutral pH, and well-aligned water safety standards with a minimal adsorbent dose (0.1 g.L-1) and economical cost ($0.05 L-1). Lastly, its environmentally friendly nature, which contains essential nutrients for plant growth, further enhances its recyclability after release. Thus, IP@C400 offers a solution to environmental sustainability and the urgent ultrapure water issue that industries are facing.

Advances in surface design and biomedical applications of magnetic nanoparticles

Despite significant efforts by scientists in the development of advanced nanotechnology materials for smart diagnosis devices and drug delivery systems, the success of clinical trials remains largely elusive. In order to address this biomedical challenge, magnetic nanoparticles (MNPs) have gained attention as a promising candidate due to their theranostic properties, which allow the simultaneous treatment and diagnosis of a disease. Moreover, MNPs have advantageous characteristics such as a larger surface area, high surface-to-volume ratio, enhanced mobility, mass transference and, more notably, easy manipulation under external magnetic fields. Besides, certain magnetic particle types based on the magnetite (Fe3O4) phase have already been FDA-approved, demonstrating biocompatible and low toxicity. Typically, surface modification and/or functional group conjugation are required to prevent oxidation and particle aggregation. A wide range of inorganic and organic molecules have been utilized to coat the surface of MNPs, including surfactants, antibodies, synthetic and natural polymers, silica, metals, and various other substances. Furthermore, various strategies have been developed for the synthesis and surface functionalization of MNPs to enhance their colloidal stability, biocompatibility, good response to an external magnetic field, etc. Both uncoated MNPs and those coated with inorganic and organic compounds exhibit versatility, making them suitable for a range of applications such as drug delivery systems (DDS), magnetic hyperthermia, fluorescent biological labels, biodetection and magnetic resonance imaging (MRI). Thus, this review provides an update of recently published MNPs works, providing a current discussion regarding their strategies of synthesis and surface modifications, biomedical applications, and perspectives.

Synthesis of an IRMOF-1@SiO2 Core-Shell and Amino-Functionalization with APTES for the Adsorption of Urea and Creatinine Using a Fixed-Bed Column Study

Kidney dysfunction is a clinical disease that disables the kidneys to remove the waste products and uremic toxins from the circulation and may lead to fatal kidney failure. Hemodialysis is advantageous in this circumstance since it prevents the accumulation of waste products in the body and facilitates the removal of uremic toxins. However, hemodialysis cannot entirely remove some uremic toxins, such as urea and creatinine. In this paper, a high-performance fixed-bed column for urea and creatinine removal was offered. As a result, a MOF layer was built on SiO₂, which was then amino-functionalized using APTES. Numerous assays were used to characterize the final adsorbent. The adsorption of urea and creatinine was evaluated in batch and continuous conditions. Thus, it was demonstrated that the adsorption behavior of A(0.2)-IRMOF-1@SiO₂ followed the Langmuir isotherm, and it exhibited the maximum adsorption capacity. The batch experiment determined that urea and creatinine had an adsorption capacity of 1325.73 and 625.00 mg·g^-1, respectively. The adsorption capacity was increased, which was due to the presence of amino groups (APTES) on the MOF surface. The continuous operation was evaluated using the A(0.2)-IRMOF-1@SiO₂ fixed-bed column. Thomas and Nelson's models were examined to achieve a better understanding of the adsorption behaviors. The A(0.2)-IRMOF-1@SiO₂ fixed-bed column successfully removed 92.57% of urea and 80.47% of creatinine. The separation factor for urea in comparison to creatinine was 2.40 in the A(0.2)-IRMOF-1@SiO₂ fixed-bed column.

Guanidinylated SBA-15/Fe3O4 mesoporous nanocomposite as an efficient catalyst for the synthesis of pyranopyrazole derivatives

In this study, a novel mesoporous nanocomposite was fabricated in several steps. In this regard, SBA-15 was prepared by the hydrothermal method, next it was magnetized by in-situ preparation of Fe3O4 MNPs. After that, the as-prepared SBA-15/Fe3O4 functionalized with 3-minopropyltriethoxysilane (APTES) via post-synthesis approach. Then, the guanidinylated SBA-15/Fe3O4 was obtained by nucleophilic addition of APTES@SBA-15/Fe3O4 to cyanimide. The prepared nanocomposite exhibited excellent catalytic activity in the synthesis of dihydropyrano[2,3-c]pyrazole derivatives which can be related to its physicochemical features such as strong basic sites (presented in guanidine group), Lewis acid site (presented in Fe3O4), high porous structure, and high surface area. The characterization of the prepared mesoporous nanocomposite was well accomplished by different techniques such as FT-IR, EDX, FESEM, TEM, VSM, TGA, XRD and BET. Furthermore, the magnetic catalyst was reused at least six consequent runs without considerable reduction in its catalytic activity.